title: FK 506 versus cyclosporine in pediatric liver transplantation.
authors.affiliation: Department of Surgery, University of Pittsburgh, PA 15213.
authors.forename: A G
authors.initials: AG
authors.lastname: Tzakis
authors.forename: J
authors.initials: J
authors.lastname: Reyes
authors.forename: S
authors.initials: S
authors.lastname: Todo
authors.forename: M
authors.initials: M
authors.lastname: Green
authors.forename: T
authors.initials: T
authors.lastname: Ohya
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: M
authors.initials: M
authors.lastname: Alessiani
authors.forename: J J
authors.initials: JJ
authors.lastname: Fung
authors.forename: T E
authors.initials: TE
authors.lastname: Starzl
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D002675:Child, Preschool; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects / Q000379:methods; D007223:Infant; D016031:Liver Transplantation / Q000009:adverse effects / Q000276:immunology* / Q000502:physiology; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D016572:Cyclosporine; D016559:Tacrolimus